| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4006432 | American Journal of Ophthalmology | 2006 | 5 Pages |
Abstract
Drug toxicities can limit the use of amphotericin in some patients with zygomycosis. Posaconazole shows promise as an alternative antifungal agent in the treatment of periorbital zygomycosis.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Tina MD, Kimberly P. MD,